HLA
ORGO icon

Hamilton Lane Advisors’s Organogenesis Holdings ORGO Stock Holding History

Hamilton Lane Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-445,985
Closed -$1.45M – 73
2022
Q3 		$1.45M Hold
445,985
– – 0.53% 25
2022
Q2 		$2.18M Hold
445,985
– – 0.84% 19
2022
Q1 		$3.4M Hold
445,985
– – 0.76% 20
2021
Q4 		$4.12M Hold
445,985
– – 0.53% 23
2021
Q3 		$6.35M Sell
445,985
-299,553
-40% -$4.65M 1.06% 14
2021
Q2 		$12.4M Buy
+745,538
New +$13.9M 3.88% 6

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Hamilton Lane Advisors's ORGO Position: Q4 2022 in Review

Hamilton Lane Advisors sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 445,985 shares — an estimated $1.45M sold.

Hamilton Lane Advisors first reported a position in ORGO in Q2 2021 and held it in 6 quarters. The position peaked at $12.4M in Q2 2021. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Hamilton Lane Advisors reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Hamilton Lane Advisors sold 445,985 Organogenesis Holdings shares in Q4 2022, an estimated $1.45M.
  • Hamilton Lane Advisors first reported a position in Organogenesis Holdings in Q2 2021 and held it in 6 quarters.
  • Hamilton Lane Advisors's Organogenesis Holdings position peaked at $12.4M in Q2 2021.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Hamilton Lane Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.